Mihajlo (Michael) Jakovljevic, University of Kragujevac, Serbia
Editor-in-Chief
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Articles
-
-
Cost-effectiveness of paclitaxel, doxorubicin, cyclophosphamide and trastuzumab versus docetaxel, cisplatin and trastuzumab in new adjuvant therapy of breast cancer in china
-
WHO key access antibiotics price, availability and affordability in private sector pharmacies in Pakistan
-
Cost-effectiveness analysis of text messaging to support health advice for smoking cessation
-
Portable continuous wave Doppler ultrasound for primary healthcare in South Africa: can the EUnetHTA Core Model guide evaluation before technology adoption?
-
Health care priority setting: principles, practice and challenges
-
Generalized cost-effectiveness analysis for national-level priority-setting in the health sector
-
Technical efficiency of public district hospitals and health centres in Ghana: a pilot study
-
Priority setting of health interventions: the need for multi-criteria decision analysis
-
Econometric estimation of country-specific hospital costs
Resource allocation in decision support frameworks
The authors discuss the traits and limitations of cost–benefit analysis, cost-effectiveness analysis, and multi-criteria decision analysis.
Part of the Priority Setting in Global Health supplement.
Aims and scope
Cost Effectiveness and Resource Allocation considers manuscripts on all aspects of cost-effectiveness analysis, including conceptual or methodological work, economic evaluations, and policy analysis related to resource allocation at a national or international level.
Editor’s Profile
Mihajlo Jakovljevic, Editor-in-Chief
Mihajlo Jakovljevic is a WHO EACHR Committee expert and Full Professor heading the Department of Global Health Economics and Policy, University of Kragujevac, Serbia. Throughout his career pathway as a clinical pharmacologist, he has specialised in health economics. Currently he holds positions at Lund University, Sweden; Division of Health Economics, IHME CHTF University of Washington, Seattle, USA and Hosei University Tokyo, Japan. While being a frequent speaker in the field, he has published over 170 full length articles in indexed, peer-reviewed journals. This scholarly work has appeared in The Lancet, JAMA, Health Economics, EJHE, Value in Health, PLOS One, Expert Reviews, JME. The focus of Professor Jakovljevic’s long term research remains the Emerging Markets’ health spending and policies. Publications
Cost-effective interventions for cancer: results from WHO-CHOICE
The team of the WHO-CHOICE program use “Generalized Cost-Effectiveness Analysis” to identify the optimal package of interventions for breast cancer, cervical cancer, and colorectal cancer.
Discount for Health Systems Global members
All Health Systems Global members receive a 20% discount on Cost Effectiveness and Resource Allocation Article Processing Charges (APCs). To claim the discount, please contact the Secretariat at info@healthsystemsglobal.org to obtain the BMC journals' discount code.
Visit our Health Services Research page
Visit our page dedicated to highlights from our Health Services Research journals. Find journal news, collections, highlights and recent campaigns, as selected by our Editors.
Annual Journal Metrics
-
Speed
145 days to first decision for reviewed manuscripts only
120 days to first decision for all manuscripts
231 days from submission to acceptance
16 days from acceptance to publicationCitation Impact
1.413 - 2-year Impact Factor
1.563 - 5-year Impact Factor
0.490 - Source Normalized Impact per Paper (SNIP)
0.776 - SCImago Journal Rank (SJR)Usage
189,720 Downloads
185 Altmetric mentions
